arrow
K

Katherine R. Calvo

national institutes of health clinical center
H指数:64
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sustained disease remission with reduced-intensity allogeneic hematopoietic cell transplant for VEXAS syndrome

VEXAS综合征患者采用减低强度异基因造血细胞移植实现持续疾病缓解

2026-11-130
OAAI
Clinical Characteristics, Management, and Hematopoietic Cell Transplantation of Patients with TLR8 Gain-of-Function
2025-12-110
OAAI
Prolonged Heparin Re-Exposure in a Patient With Previous Heparin-Induced Thrombocytopenia (HIT)

对既往有肝素诱导血小板减少症(HIT)病史的患者进行肝素再暴露治疗

2025-09-010
PRE
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

美国风湿病学会关于VEXAS诊断与管理的指南声明,由国际VEXAS工作组专家委员会制定

2025-08-110
OAAI
Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML

单细胞空间转录组学揭示免疫疗法驱动的AML骨髓微环境重塑

2025-07-090
OAAI
A Phase 2 Response-Adapted Study of Daratumumab, Carfilzomib, and Dexamethasone (DKd) in Patients with High-Risk Smoldering Multiple Myeloma

一项关于达鲁珠单抗、卡非佐米和地塞米松(DKd)在高危冒烟型多发性骨髓瘤患者中的2期适应性研究

BLOOD
IF23.1
2024-11-050
PRE
A unified metric of human immune health

人体免疫健康的统一度量

2024-07-033
OA
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
2023-10-0212
OAAI
Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome

组成型活性Lyn激酶引起皮肤小血管血管炎和肝纤维化综合征

2023-03-1712
OAAI